- Home
- MTVA vs GYRO Comparison
MTVA vs GYRO Comparison
Compare MTVA & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- GYRO
- Stock Information
- Founded
- MTVA 2014
- GYRO 1946
- Country
- MTVA United States
- GYRO United States
- Employees
- MTVA N/A
- GYRO N/A
- Industry
- MTVA
- GYRO Building operators
- Sector
- MTVA
- GYRO Real Estate
- Exchange
- MTVA NYSE
- GYRO Nasdaq
- Market Cap
- MTVA 16.8M
- GYRO 19.8M
- IPO Year
- MTVA N/A
- GYRO N/A
- Fundamental
- Price
- MTVA $1.74
- GYRO $9.02
- Analyst Decision
- MTVA Strong Buy
- GYRO
- Analyst Count
- MTVA 1
- GYRO 0
- Target Price
- MTVA $12.00
- GYRO N/A
- AVG Volume (30 Days)
- MTVA 57.9K
- GYRO 402.0
- Earning Date
- MTVA 03-27-2025
- GYRO 01-01-0001
- Dividend Yield
- MTVA N/A
- GYRO N/A
- EPS Growth
- MTVA N/A
- GYRO N/A
- EPS
- MTVA N/A
- GYRO N/A
- Revenue
- MTVA N/A
- GYRO $2,738,019.00
- Revenue This Year
- MTVA N/A
- GYRO N/A
- Revenue Next Year
- MTVA N/A
- GYRO N/A
- P/E Ratio
- MTVA N/A
- GYRO N/A
- Revenue Growth
- MTVA N/A
- GYRO N/A
- 52 Week Low
- MTVA $1.51
- GYRO $7.65
- 52 Week High
- MTVA $6.75
- GYRO $11.96
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- GYRO 39.82
- Support Level
- MTVA N/A
- GYRO $9.02
- Resistance Level
- MTVA N/A
- GYRO $9.50
- Average True Range (ATR)
- MTVA 0.00
- GYRO 0.04
- MACD
- MTVA 0.00
- GYRO 0.00
- Stochastic Oscillator
- MTVA 0.00
- GYRO 0.00
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About GYRO Gyrodyne LLC
Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.